Show simple item record

dc.contributor.advisorAragon, Patrick J.
dc.contributor.authorDrayton, Antwana Letoya
dc.date.accessioned2021-11-01T17:18:51Z
dc.date.available2021-11-01T17:18:51Z
dc.date.created2023-05
dc.date.issued2021-09
dc.date.submittedMay 2023
dc.identifier.urihttp://hdl.handle.net/11141/3432
dc.descriptionThesis (Psy.D.) - Florida Institute of Technology, 2021.en_US
dc.description.abstractOpioid Use Disorder (OUD) has been a long-standing epidemic concern related to the continuous growth of variations of the substance and its’ potency. Due to the versatility of the substance to be both an illicit drug and also a prescription medication, the interest in controlling and monitoring its’ use creates a greater public health concern. Treatment overtime has been revitalized to directly address the social, biological, and physiological difficulties of patients with OUDs. Medication Assisted Treatment (MAT) has been explored and has become one of the most widely used plans for treatment of Substance Use Disorders (SUDs) related to pain management issues, dependency, withdrawal, and likelihood of maintaining sobriety. The use of MAT has been proven to be a positive and worthwhile addition to the treatment of OUDs. However, there are gaps in the administration and enrollment of individuals into the programs and facilities that offer MAT services. As this deficit is acknowledged, the current study was posed to examine the relationships among demographic factors relative to OUDs and MAT services. Data from a sample of 973 adults with a diagnosis of OUD relative to all opioid related substances, was analyzed in this study. Relationships among gender, race, employment, education, and types of treatment were explored. Types of treatment included Suboxone and Vivitrol. Overall, this study found that Suboxone treatment was administered more often than Vivitrol treatment. Also, outpatient service members used MAT services more often than inpatient members. Chi-square analyses and an Analysis of Variance were both utilized, indicating gender differences and educational differences. Likewise, specific race differences and employment attainment computed no significant conclusions. Contributions to the findings, limitations of the exploration, and future research directions are all discussed.en_US
dc.format.mimetypeapplication/pdf
dc.language.isoen_USen_US
dc.rightsCC BY 4.0en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.subjectDemographicsen_US
dc.subjectTreatmenten_US
dc.subjectRecidivismen_US
dc.subjectMedicationen_US
dc.subjectOpioiden_US
dc.subjectVivitrolen_US
dc.subjectSuboxoneen_US
dc.titleMedication Assisted Treatment: Examining Enrollment and Demographic Factors of Treatmenten_US
dc.typeDoctoral Research Projecten_US
dc.date.updated2021-10-20T15:46:12Z
thesis.degree.nameDoctor of Psychology in Clinical Psychologyen_US
thesis.degree.levelDoctoralen_US
thesis.degree.disciplineClinical Psychologyen_US
thesis.degree.departmentPsychologyen_US
thesis.degree.grantorFlorida Institute of Technologyen_US
dc.type.materialtext


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY 4.0
Except where otherwise noted, this item's license is described as CC BY 4.0